NCT06698822 2026-04-14
A Phase 2 Trial to Assess Safety and Efficacy of Tofacitinib 2% Cream in the Treatment of Cutaneous T-cell Lymphoma (CTCL), Stages IA, IB, and IIA
M.D. Anderson Cancer Center
Phase 2 Recruiting
Clinical Trials
7 trialsNCT05326464 2025-12-15
Tofacitinib in Recurrent GBM Patients
University of Texas Southwestern Medical Center
Phase 3 Active not recruiting
NCT04431895 2025-09-16
Safety And Efficacy Of Tofacitinib In Patients With Refractory Myasthenia Gravis: A Pilot Study
Huashan Hospital
Phase EARLY_PHASE1 Completed
NCT03976245 2024-11-29
Advanced Therapeutics in Rheumatoid Arthritis (RA)
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase 4 Recruiting
NCT05348213 2024-10-23
R-ICE+X
Ruijin Hospital
Phase 2 Recruiting
NCT04798287 2022-06-22
STAR-RA-Cancer
Brigham and Women's Hospital
Completed
NCT03598959 2018-07-26
Tofacitinib Combined With Chidamide in R/R ENKTCL
Sichuan University
Phase 2 Unknown